View in EDS HTML Full Text PDF Full Text

Engineered Multivalent Nanobodies Potently and Broadly Neutralize SARS-CoV-2 Variants.

Saved in:
Bibliographic Details
Title: Engineered Multivalent Nanobodies Potently and Broadly Neutralize SARS-CoV-2 Variants.
Authors: Zupancic JM; Department of Chemical Engineering University of Michigan Ann Arbor MI 48109 USA.; Biointerfaces Institute University of Michigan Ann Arbor MI 48109 USA., Schardt JS; Department of Chemical Engineering University of Michigan Ann Arbor MI 48109 USA.; Biointerfaces Institute University of Michigan Ann Arbor MI 48109 USA.; Department of Pharmaceutical Sciences University of Michigan Ann Arbor MI 48109 USA., Desai AA; Department of Chemical Engineering University of Michigan Ann Arbor MI 48109 USA.; Biointerfaces Institute University of Michigan Ann Arbor MI 48109 USA., Makowski EK; Biointerfaces Institute University of Michigan Ann Arbor MI 48109 USA.; Department of Pharmaceutical Sciences University of Michigan Ann Arbor MI 48109 USA., Smith MD; Department of Chemical Engineering University of Michigan Ann Arbor MI 48109 USA.; Biointerfaces Institute University of Michigan Ann Arbor MI 48109 USA., Pornnoppadol G; Biointerfaces Institute University of Michigan Ann Arbor MI 48109 USA.; Department of Pharmaceutical Sciences University of Michigan Ann Arbor MI 48109 USA., Garcia de Mattos Barbosa M; Department of Surgery University of Michigan Ann Arbor MI 48109 USA., Cascalho M; Department of Surgery University of Michigan Ann Arbor MI 48109 USA.; Department of Microbiology and Immunology University of Michigan Ann Arbor MI 48109 USA., Lanigan TM; Division of Rheumatology Department of Internal Medicine University of Michigan Medical School Ann Arbor MI 48109 USA., Tessier PM; Department of Chemical Engineering University of Michigan Ann Arbor MI 48109 USA.; Biointerfaces Institute University of Michigan Ann Arbor MI 48109 USA.; Department of Pharmaceutical Sciences University of Michigan Ann Arbor MI 48109 USA.; Department of Biomedical Engineering University of Michigan Ann Arbor MI 48109 USA.
Source: Advanced therapeutics [Adv Ther (Weinh)] 2021 Aug; Vol. 4 (8), pp. 2100099. Date of Electronic Publication: 2021 Aug 02.
Publication Type: Journal Article
Journal Info: Publisher: WILEY-VCH Verlag GmbH & Co. KGaA Country of Publication: Germany NLM ID: 101724632 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2366-3987 (Electronic) Linking ISSN: 23663987 NLM ISO Abbreviation: Adv Ther (Weinh) Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 34514086
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Engineered Multivalent Nanobodies Potently and Broadly Neutralize SARS-CoV-2 Variants.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Zupancic+JM%22">Zupancic JM</searchLink>; Department of Chemical Engineering University of Michigan Ann Arbor MI 48109 USA.; Biointerfaces Institute University of Michigan Ann Arbor MI 48109 USA.<br /><searchLink fieldCode="AU" term="%22Schardt+JS%22">Schardt JS</searchLink>; Department of Chemical Engineering University of Michigan Ann Arbor MI 48109 USA.; Biointerfaces Institute University of Michigan Ann Arbor MI 48109 USA.; Department of Pharmaceutical Sciences University of Michigan Ann Arbor MI 48109 USA.<br /><searchLink fieldCode="AU" term="%22Desai+AA%22">Desai AA</searchLink>; Department of Chemical Engineering University of Michigan Ann Arbor MI 48109 USA.; Biointerfaces Institute University of Michigan Ann Arbor MI 48109 USA.<br /><searchLink fieldCode="AU" term="%22Makowski+EK%22">Makowski EK</searchLink>; Biointerfaces Institute University of Michigan Ann Arbor MI 48109 USA.; Department of Pharmaceutical Sciences University of Michigan Ann Arbor MI 48109 USA.<br /><searchLink fieldCode="AU" term="%22Smith+MD%22">Smith MD</searchLink>; Department of Chemical Engineering University of Michigan Ann Arbor MI 48109 USA.; Biointerfaces Institute University of Michigan Ann Arbor MI 48109 USA.<br /><searchLink fieldCode="AU" term="%22Pornnoppadol+G%22">Pornnoppadol G</searchLink>; Biointerfaces Institute University of Michigan Ann Arbor MI 48109 USA.; Department of Pharmaceutical Sciences University of Michigan Ann Arbor MI 48109 USA.<br /><searchLink fieldCode="AU" term="%22Garcia+de+Mattos+Barbosa+M%22">Garcia de Mattos Barbosa M</searchLink>; Department of Surgery University of Michigan Ann Arbor MI 48109 USA.<br /><searchLink fieldCode="AU" term="%22Cascalho+M%22">Cascalho M</searchLink>; Department of Surgery University of Michigan Ann Arbor MI 48109 USA.; Department of Microbiology and Immunology University of Michigan Ann Arbor MI 48109 USA.<br /><searchLink fieldCode="AU" term="%22Lanigan+TM%22">Lanigan TM</searchLink>; Division of Rheumatology Department of Internal Medicine University of Michigan Medical School Ann Arbor MI 48109 USA.<br /><searchLink fieldCode="AU" term="%22Tessier+PM%22">Tessier PM</searchLink>; Department of Chemical Engineering University of Michigan Ann Arbor MI 48109 USA.; Biointerfaces Institute University of Michigan Ann Arbor MI 48109 USA.; Department of Pharmaceutical Sciences University of Michigan Ann Arbor MI 48109 USA.; Department of Biomedical Engineering University of Michigan Ann Arbor MI 48109 USA.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101724632%22">Advanced therapeutics</searchLink> [Adv Ther (Weinh)] 2021 Aug; Vol. 4 (8), pp. 2100099. <i>Date of Electronic Publication: </i>2021 Aug 02.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22WILEY-VCH+Verlag+GmbH+%26+Co%2E+KGaA%22">WILEY-VCH Verlag GmbH & Co. KGaA </searchLink><i>Country of Publication: </i>Germany <i>NLM ID: </i>101724632 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2366-3987 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2223663987%22">23663987 </searchLink><i>NLM ISO Abbreviation: </i>Adv Ther (Weinh) <i>Subsets: </i>PubMed not MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=34514086
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1002/adtp.202100099
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 2100099
    Titles:
      – TitleFull: Engineered Multivalent Nanobodies Potently and Broadly Neutralize SARS-CoV-2 Variants.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Zupancic JM
      – PersonEntity:
          Name:
            NameFull: Schardt JS
      – PersonEntity:
          Name:
            NameFull: Desai AA
      – PersonEntity:
          Name:
            NameFull: Makowski EK
      – PersonEntity:
          Name:
            NameFull: Smith MD
      – PersonEntity:
          Name:
            NameFull: Pornnoppadol G
      – PersonEntity:
          Name:
            NameFull: Garcia de Mattos Barbosa M
      – PersonEntity:
          Name:
            NameFull: Cascalho M
      – PersonEntity:
          Name:
            NameFull: Lanigan TM
      – PersonEntity:
          Name:
            NameFull: Tessier PM
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 08
              Text: 2021 Aug
              Type: published
              Y: 2021
          Identifiers:
            – Type: issn-electronic
              Value: 2366-3987
          Numbering:
            – Type: volume
              Value: 4
            – Type: issue
              Value: 8
          Titles:
            – TitleFull: Advanced therapeutics
              Type: main
ResultId 1